Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: AstraZeneca
Breast Cancer, Early Breast Cancer
United States, Argentina, Australia, Austria, Belgium +34 more
- A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Sjogrens Syndrome
United States, Argentina, Australia, Austria, Belgium +30 more
Sponsor: GlaxoSmithKline
Gastrointestinal Stromal Neoplasms
United States, Argentina, Canada, China, Japan +2 more
Sponsor: BeOne Medicines
Advanced Solid Tumor · Advanced Breast Cancer · Metastatic Breast Cancer · Hormone-receptor-positive Breast Cancer
United States, Australia, Brazil, China, France +6 more
- DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine CancersNot Yet Recruiting
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer · Large Cell Neuroendocrine Lung Carcinoma · Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology · Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
United States, Australia, Belgium, China, France +6 more
Sponsor: Insmed Incorporated
Pulmonary Arterial Hypertension
United States, Japan
Sponsor: Bayer
Advanced Non-small Cell Lung Cancer, HER2 Mutation
United States, Argentina, Australia, Austria, Belgium +31 more
Sponsor: Boehringer Ingelheim
Proteinuric Kidney Diseases
United States, Argentina, Australia, Belgium, Brazil +28 more
- Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic AlterationsActive Not Recruiting
Sponsor: Daiichi Sankyo
Metastatic Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Novartis Pharmaceuticals
Atopic Dermatitis
United States, Argentina, Canada, China, Czechia +12 more
Sponsor: Akero Therapeutics, Inc
NASH - Nonalcoholic Steatohepatitis · MASH - Metabolic Dysfunction-Associated Steatohepatitis
United States, Argentina, Australia, Brazil, Canada +15 more
- A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular CarcinomaActive Not Recruiting
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, Japan, South Korea
Sponsor: Merck Sharp & Dohme LLC
Pulmonary Arterial Hypertension
Japan
- A Phase 2 Study of YA-101 in Patients With Multiple System AtrophyActive Not Recruiting
Sponsor: Dasher Neuroscience Inc.
Multiple System Atrophy
United States, Japan, Taiwan
Sponsor: BeOne Medicines
Mantle Cell Lymphoma · B Cell Lymphoma
United States, Argentina, Australia, Austria, Brazil +12 more
Sponsor: Boehringer Ingelheim
Solid Tumours
United States, Australia, Belgium, Canada, China +11 more
Sponsor: AstraZeneca
Multiple Myeloma
United States, Australia, Brazil, Canada, China +4 more
Sponsor: Biogen
Primary Membranous Nephropathy
United States, Argentina, Australia, Brazil, Canada +6 more
Sponsor: CSL Behring
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
United States, Canada, Japan, Mexico
Sponsor: AstraZeneca
Bronchiectasis With Pseudomonas Aeruginosa Colonization
United States, Argentina, Australia, Belgium, Brazil +20 more
Sponsor: Boehringer Ingelheim
Fibrosing Interstitial Lung Disease
United States, Argentina, Australia, Belgium, Brazil +17 more
Sponsor: Sanofi
Ulcerative Colitis
United States, Canada, Georgia, Japan, Lithuania +3 more
Sponsor: Dianthus Therapeutics
Chronic Inflammatory Demyelinating Polyneuropathy
United States, Argentina, Australia, Belgium, Brazil +24 more
Sponsor: Merck Sharp & Dohme LLC
Esophageal Squamous Cell Carcinoma
United States, Brazil, Chile, China, Czechia +10 more
Sponsor: Novo Nordisk A/S
Obesity · Heart Failure
United States, Argentina, Australia, Brazil, Bulgaria +22 more